Prism Medico and Pharmacy Ltd

NSE: PRISMMEDI · BSE: 512217 · Commercial Services & Supplies · 4 announcements

Share price: ₹28.83
Market cap: ₹39.10 Cr
Revenue (annual): ₹2.44 Cr
Net profit (annual): ₹0.32 Cr
P/E (TTM): -98.4×Sector 41.4×
Promoter holding: 29.98%+4.49% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 2 Management Change 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

4 announcements

19 Sep 2026 19:19 IST BSE

Management Change

Prism Medico and Pharmacy Management Change

Prism Medico and Pharmacy Limited re-appointed Davender Singh as a Non-Executive Non-Independent Director. The company also updated its statutory and secretarial auditor appointments.

Read the filing ↗

19 Sep 2026 13:19 IST BSE

Annual General Meeting

Prism Medico and Pharmacy Annual General Meeting

Prism Medico and Pharmacy held its 24th Annual General Meeting on September 19, 2026, to transact ordinary and special business, including various investment approvals.

Read the filing ↗

12 Aug 2026 15:50 IST BSE

Financial Results

Prism Medico and Pharmacy Q1 FY27 Results: Net Loss of ₹0.1 Cr

Prism Medico and Pharmacy Ltd reported a net loss of ₹0.1 Cr for Q1 FY27.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗

28 May 2026 17:10 IST BSE

Financial Results

Prism Medico and Pharmacy Q4 FY26 Results: Net Loss of ₹0.2 Cr

Prism Medico and Pharmacy Ltd reported revenue from operations of ₹0.3 Cr (+200.0% YoY) and a net loss of ₹0.2 Cr for Q4 FY26.

Key figure: Net loss ₹0.2 Cr

Open full results → Read the filing ↗